CA-074 Me | CAS# 147859-80-1APExBIO 貨號A8239

| 代理廠牌: | ![]() |
| 原廠連結: | |
| 相關下載: |
蛋白酶(Proteases)系列商品->>CA-074 Me
APExBIO Technology LLC 是一家領先的小分子抑制劑 (Small Molecule Inhibitors)/活化劑(Activators)、化合物庫( Compound Libraries)、胜肽(Peptides)、檢測試劑盒(Assay Kits)、螢光標記(Fluorescent Label)、酶(Enzymes)、修飾核苷酸(Modified Nucleotides)、mRNA 合成以及各種分子生物學工具的供應商。APExBIO提供廣泛的產品線,涵蓋 20 多個不同的研究領域,例如癌症(cancer)、免疫學(immunology)、神經科學(neurosciences)、細胞凋亡(apoptosis)和表觀遺傳學(epigenetics)等。公司總部位於美國德州休士頓USA (Houston, Texas),致力於服務全球客戶。高度重視產品品質。所有產品均遵循嚴格的生產指南,並附有分析證書、HPLC、質譜(Mass Spectrum)和HMNR以及體外驗證(in vitro validation)。 APExBIO產品已被《Nature》、《Cell》和《Science》等眾多頂級同行評審期刊引用。>>更多APExBio商品

蛋白酶(Proteases)也稱為肽酶(peptidases)或蛋白水解酶(proteolytic enzymes),由大量催化肽鍵水解(hydrolysis)並隨後導致蛋白質底物(protein substrates)降解為氨基酸(amino acids)的酶組成。蛋白酶(Proteases)與多種人類疾病有關,包括癌症(cancer)、神經退行性疾病(neurodegenerative disorders)、炎症性疾病(inflammatory diseases)和心血管疾病(cardiovascular diseases)。因此,許多蛋白酶抑制劑【小分子(small molecules)和蛋白質】已被鑑定為阻斷蛋白酶的活性(proteases)。蛋白酶抑制劑可以根據它們通過兩種一般機制抑制的蛋白酶類別分為不同的類型,即不可逆的“捕獲(trapping)”反應和可逆(reversible)的緊密結合反應。蛋白酶抑制劑已被用作治療蛋白酶相關疾病的診斷劑(diagnostic)或治療劑(therapeutic agents)。
CA-074 Me | CAS# 147859-80-1APExBIO 貨號A8239
Product Citation+6
Cathepsin B inhibitor
CA-074 Me is a membrane-permeable and selective inhibitor of cathepsin B with IC50 value of 36.3 nM [1, 2].

CA-074 Me 是一種可透過膜的選擇性組織蛋白酶 B (cathepsin B)抑制劑,IC50 值為 36.3 nM [1, 2]。CA-074 Me 是 CA-074 的甲酯衍生物(methyl ester derivative)。在培養的人牙齦成纖維細胞(human gingival fibroblasts)中,CA-074 Me 對組織蛋白酶 B (cathepsins B)有 95% 的抑制作用,對組織蛋白酶 B cathepsin B)和 L (cathepsin L)的聯合活性有部分抑制作用 (54%)。還發現 CA-074 Me 在還原條件下抑制組織蛋白酶 L (cathepsin L)。當酶與 1.4 mM DTT 或 4.2 mM GSH 預孵育 2 小時時,它抑制純化的人組織蛋白酶 L (cathepsin L) 的活性超過 90%。除此之外,CA-074 Me 在 1.4 mM DTT 存在下完全抑制組織蛋白酶 B (cathepsin B) [2, 3]。
- Jianhua Wang, Lichun Wang, et al. “Cathepsin B aggravates acute pancreatitis by activating the NLRP3 inflammasome and promoting the caspase-1-induced pyroptosis.” Int Immunopharmacol. 2021 May;94:107496.PMID:33639565
- Zhi X, Zhang Y, et al. “NLRP3 inflammasome activation by Foot-and-mouth disease virus infection mainly induced by viral RNA and non-structural protein 2B.” RNA Biol. 2020;17(3):335–349.PMID:31840571
- Zhou H, Du R, et al. “Cannabinoid receptor 2 promotes the intracellular degradation of HMGB1 via the autophagy-lysosome pathway in macrophage.” Int Immunopharmacol. 2020;78:106007.PMID:31806570
- Chen CH, Bhasin S, et al. “Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts.” Oncogenesis. 2019 Feb 22;8(3):15.PMID:30796200
- Xu Z, Zhang Y, et al. “Novel half-sandwich iridium OˆC (carbene)-Complexes: In vitro and in vivo tumor growth suppression and pro-apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes.” Cancer Lett. 2019 Apr 10;447:75-85.PMID:30673591
- Yan X, Li F, et al. “Interleukin-1beta released by microglia initiates the enhanced glutamatergic activity in the spinal dorsal horn during paclitaxel-associated acute pain syndrome.” Glia. 2018 Dec 21.PMID:30578561



| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 397.5 |
| Cas No. | 147859-80-1 |
| Formula | C19H31N3O6 |
| Solubility | insoluble in H2O; ≥19.88 mg/mL in DMSO; ≥51.5 mg/mL in EtOH with ultrasonic |
| Chemical Name | methyl (2S)-1-[(2S)-3-methyl-2-[[(2S,3S)-3-(propylcarbamoyl)oxirane-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carboxylate |
| SDF | Download SDF |
| Canonical SMILES | CCCNC(=O)C1C(O1)C(=O)NC(C(C)CC)C(=O)N2CCCC2C(=O)OC |
| Shipping Condition | Ship with blue ice, or upon other requests. |
| General tips | For obtaining a higher solubility, please warm the tube at 37°C and shake it in the ultrasonic bath for a while. We do not recommend long-term storage for the solution, please use it up soon. |


| 品項 | CAS# | #貨號 | 應用 |
| Z-VAD-FMK | CAS# 187389-52-2 | 貨號 A1902 |
Proteases ICE-like proteases |
| TAPI-1 | CAS#171235-71-5 | 貨號 B4686 |
Proteases TACE/ADAM17 inhibitor Product Citation+3 |
| Talabostat mesylate | CAS# 150080-09-4 | 貨號B3941 |
Proteases DPP4 二肽基肽酶特異性抑制劑 |
| Z-IETD-FMK | CAS# 210344-98-2 | 貨號B3232 | inhibitor of caspase 8 |
| Cisplatin | CAS# 15663-27-1 | 貨號A8321 | 高效、廣譜的化療藥物 |
| 17-DMAG (Alvespimycin) HCl | CAS#467214-21-7 | 貨號A2213 | Hsp90 inhibitor |
| CA-074 Me | CAS# 147859-80-1 | 貨號A8239 | Cathepsin B inhibitor |
| VX-765 | CAS# 273404-37-8 | 貨號A8238 | Caspase-1 inhibitor |
- COA (Certificate Of Analysis)
- HPLC (Retest)
- NMR (Nuclear Magnetic Resonance)
- MSDS (Material Safety Data Sheet)
- Datasheet

APExBIO台灣代理商: https://www.apexbt.com/
APExBIO提供優質的胜肽和生物分析試劑,廣泛產品線如Protease、Chromatin/Epigenetics表觀遺傳學、MAPK Signal、DNA Damege/DNA repair、細胞凋亡、腫瘤生物學、Stem cell等研究領域, 還提供定制的服務,包括多肽合成,抗體的生產和檢測的發展。產品線DNA/RNA prep kit、Drug Screening panel、Bioactive peptides、Growth factors、Biotinylation Reagents、tag peptides、amino Acids、Growth factors等。APExBIO產品質量都伴隨著證書的分析,高效液相色譜,質譜,和HMNR數據。

